1. Home
  2. CLBT vs ARQT Comparison

CLBT vs ARQT Comparison

Compare CLBT & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cellebrite DI Ltd.

CLBT

Cellebrite DI Ltd.

HOLD

Current Price

$11.08

Market Cap

3.5B

Sector

Technology

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$24.24

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLBT
ARQT
Founded
1999
2016
Country
Israel
United States
Employees
1285
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CLBT
ARQT
Price
$11.08
$24.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$22.50
$34.00
AVG Volume (30 Days)
1.5M
1.1M
Earning Date
05-13-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
88.79
EPS
N/A
N/A
Revenue
N/A
$376,072,000.00
Revenue This Year
$21.45
$34.46
Revenue Next Year
$17.47
$29.77
P/E Ratio
$45.29
N/A
Revenue Growth
N/A
91.34
52 Week Low
$11.76
$12.42
52 Week High
$20.53
$31.77

Technical Indicators

Market Signals
Indicator
CLBT
ARQT
Relative Strength Index (RSI) 27.95 52.71
Support Level N/A $22.56
Resistance Level $15.17 $25.03
Average True Range (ATR) 0.75 0.96
MACD -0.22 0.35
Stochastic Oscillator 3.44 77.75

Price Performance

Historical Comparison
CLBT
ARQT

About CLBT Cellebrite DI Ltd.

Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: